HMGB1/TKR4/NF-κB |
Memantine alleviated pain indicators in diabetic mice and suppressed excessive NMDAR1 activation, glutamate, and pro-inflammatory cytokine release in the spinal cord. Furthermore, memantine combats the HMGB1/TLR4/NF-kB axis and modulates overactive glutamate spinal transmission |
[49] |
NF-κB |
NF-κB expression in diabetic sciatic endothelial cells and Schwann cells increased significantly, with a 2-fold increase in NF-κB and ICAM-1 expression density in diabetic nerve microvessels. Moreover, diabetic nerves experience an increased inflammatory response due to IR injury, possibly due to NF-κB activation |
[48] |
TNF-α/NF-κB |
Increased Nav1.7 in DRG neurons of rats with DN was linked to increased TNF-α, which was inhibited by thalidomide and pyrrolidine dithiocarbamate. The NF-κB is involved in this process |
[53] |
MAPK/NF-κB |
GLP-1R agonists prevent nerve dysfunction in the sciatic nerves of diabetic rats via p38 MAPK/NF-κB is independent of glycemic control |
[77] |
NF-κB |
The study reveals that ZJME, ARBWF, and ZJWF, when combined with insulin, can reduce thermal, mechanical hyperalgesia, cold allodynia in diabetic neuropathic rats, reducing oxidative stress, NF-κB, and iNOS-mediated inflammatory cascades |
[78] |
NF-κB |
HG treatment increased DRG neuron apoptosis by increasing ROS levels and activating the NF-κB. Quercetin, when combined with HG, decreased caspase-3 activation and apoptosis, directly scavenging ROS, increasing Nrf-2 and HO-1 expression, and inhibiting NF-κB signaling, suppressing inflammatory cytokines |
[79] |
NF-κB |
The study confirms the NF-κB inhibitory and anti-inflammatory activity of resveratrol, which may contribute to neuroprotection in diabetic neuropathy, by decreasing p65 and IκB-α expression, ameliorating elevated TNF-α, IL-6, and COX-2 levels, and reducing nerve MDA levels |
[80] |
TLR4/NF-κB |
Quercetin reduced inflammatory factors in diabetic pancreatic cancer (DPN) rats by downregulating the TLR4/MyD88/NF-κB. Despite not decreasing blood glucose levels or reversing weight loss, it demonstrated anti-inflammatory and neuroprotective effects, making it beneficial for DPN treatment |
[81] |
NF-κB |
Curcumin can enhance spinal cord changes, inhibit Iba1, GFAP, caspase-3, and NF-kB expression, increase NeuN expression, and restore Nrf2/HO-1 signaling, thus suppressing diabetic spinal cord central neuropathy, glial activation, and neuronal apoptosis |
[82] |
NF-κB |
DRG neurons' apoptosis was enhanced in diabetic conditions, which was lessened by QCH formula treatment. The possible reason could be activating Nrf-2/HO-1, scavenging ROS, and prevention of NF-κB activation. The effect of QCH combination was better than each monomer or the combination of the two monomers |
[83] |
NF-κB |
Melatonin reduces NF-κB, IκB-α, and phosphorylated IκB-α expression, proinflammatory cytokines, and DNA fragmentation in animal sciatic nerves. It modulates Nrf2, increasing heme oxygenase-1 expression and strengthening antioxidant defense. Melatonin has neuroprotective effect in diabetic neuropathy |
[76] |